Armistice Capital’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-460,000
| Closed | -$966K | – | 260 |
|
|
2024
Q4 | $966K | Buy |
+460,000
| New | +$966K | 0.01% | 163 |
|
|
2024
Q3 | – | Sell |
-1,020,000
| Closed | -$2.84M | – | 298 |
|
|
2024
Q2 | $2.84M | Buy |
+1,020,000
| New | +$2.84M | 0.04% | 133 |
|
|
2023
Q4 | – | Sell |
-889,272
| Closed | -$889K | – | 330 |
|
|
2023
Q3 | $889K | Buy |
+889,272
| New | +$889K | 0.01% | 144 |
|